The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

LGP by the numbers
More From The Market Online
The words "Market Open ASX 200 Futures Tip FALL" appear stacked atop one another next to ASX company iconography.

ASX Market Open: Tech fumble on Wall Street to seep into Week 51 opening | Dec 15

ASX today – Australian shares are heading for a Monday fall, with futures down as much…
The Market Online Video

HotCopper Highlights, Week 50: 4DX above $2/sh, Nanoveu, Ovanti & more

Good Afternoon and welcome to HotCopper Highlights wrapping up Week 50 of the year, I’m Jon Davidson.

‘Potential is enormous’: GreenX likes what it’s found in Tannenberg, is activating acquisition option

GreenX Metals has activated an option to secure control of the Tannenberg Copper Project in Germany,…
The Market Online Video

ASX Market Open: Oz shares heading for W50 weekly gains with Friday rally | Dec 12

ASX today – The third-last week of CY25 may actually end on gains, with a late-on…